Loading
STERIS plc Stock: price and insider trades · United States
Insider Decl.
889
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€290M
265 ops. · all time
Who traded when
BuySaleDaniel A. Carestio6 sales
Tamaro Renato4 sales
Majors Cary L3 sales
Zangerle John Adam3 sales
Feldmann Cynthia L2 sales
Madsen Julia2 sales
+3 other insiders
Analyst consensus: bullish or bearish?
Analysts rate STERIS plc Buy (bullish), based on 6 analysts. Average price target: US$259.17.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,065 of 26,246 companies
59.2
score / 100
Value50
Quality68
FCF yld4.4%
Earn yld3.6%
EV/EBITDA15.1x
ROE11%
Gross mgn44%
Net mgn13%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
US$225.18
Analyst consensus
6 analystsBuy
US$232.00Target US$259.17(+15%)US$275.00
Income statement
RevenueUS$5.9B
Gross profitUS$2.6B44% margin
EBITDAUS$1.6B27% margin
Net incomeUS$782.3M13.3% margin
Valuation
PER (trailing)27.5x
PER (forward)18.3x
P/Book3.0x
Beta0.93
Balance sheet & cash
Market capUS$22B
Total debtUS$2.1B
Free Cash FlowUS$972.4M
Debt / Equity28%
Profitability & ownership
ROE11.4%
ROA6.8%
% insiders0.3%
% institutions100.9%
Last declaration on 5 October 2026
Declarations889 total
228 shares0Ordinary SharesSEC:0001628280-26-064926:0
4,110 shares@ US$231.90120.0046% mcap15.6% of flowOrdinary SharesSEC144:0001921094-26-000904
4,058 shares@ US$235.7760.0046% mcap35.0% of flowOrdinarySEC144:0001921094-26-000838
4,058 shares@ US$86.230.0017% mcap12.8% of flowOrdinary SharesSEC:0001628280-26-056270:0
4,058 shares@ US$235.780.0046% mcap35.0% of flowOrdinary SharesSEC:0001628280-26-056270:1
1,419 shares@ US$209.27980.0013% mcap6.6% of flowOrdinarySEC144:0001921094-26-000650
90 shares@ US$212.240.0001% mcap0.7% of flowOrdinary SharesSEC:0001628280-26-041625:0
1,889 shares@ US$212.240.0016% mcap6.3% of flowOrdinary SharesSEC:0001628280-26-041629:0
3,054 shares@ US$214.640.0027% mcap10.3% of flowOrdinary SharesSEC:0001628280-26-041629:1
1,374 shares@ US$212.000.0012% mcap4.6% of flowOrdinary SharesSEC:0001628280-26-041629:2
1,374 shares@ US$212.000.0013% mcap4.6% of flowOrdinarySEC144:0001921094-26-000609
190 shares@ US$210.190.0002% mcap1.4% of flowOrdinary SharesSEC:0001628280-26-041274:0
2,619 shares@ US$210.190.0023% mcap8.6% of flowOrdinary SharesSEC:0001628280-26-041275:0
3,054 shares@ US$214.64010.0030% mcap10.3% of flowOrdinarySEC144:0001921094-26-000604
3,781 shares@ US$71.400.0011% mcap4.4% of flowOrdinary SharesSEC:0001628280-26-040830:0
1,481 shares@ US$209.510.0013% mcap5.1% of flowOrdinary SharesSEC:0001628280-26-040830:1
995 shares@ US$209.760.0009% mcap3.3% of flowOrdinary SharesSEC:0001628280-26-040835:1
591 shares@ US$209.760.0005% mcap26.6% of flowOrdinary SharesSEC:0001628280-26-040838:1
5,325 shares0Ordinary SharesSEC:0001628280-26-040833:0
23,736 shares0Ordinary SharesSEC:0001628280-26-040835:0
3,009 shares0Ordinary SharesSEC:0001628280-26-040838:0
66 shares@ US$209.760.0001% mcap0.5% of flowOrdinary SharesSEC:0001628280-26-040833:1
1,254 shares0Ordinary SharesSEC:0001628280-26-040430:0
99 shares0Ordinary SharesSEC:0001628280-26-040426:0
1,481 shares@ US$209.51050.0014% mcap5.1% of flowOrdinary SharesSEC144:0001921094-26-000594
25 of 889 declarations
About STERIS plc
No purchase appears among the 889 insider filings of STERIS plc, a US healthcare company valued at USD 22 billion. The flow is made up of 265 sales worth EUR 290,128,017 (median EUR 408,752), 403 grants, 151 option exercises and 70 other filings.
Richard Martin Steeves (Director) made the three largest sales: EUR 22,992,134 on June 7, 2019, EUR 12,869,621 on June 4, 2019 and EUR 11,304,749 on September 8, 2017. The most frequent filer is Walter M. Rosebrough Jr. (President & CEO) with 100 filings, 46 of them sales. Michael J. Tokich (Sr. Vice Pres., CFO) signs 77 and Karen L. Burton (Sr. Vice Pres., CFO) 74, both under the same job title; Daniel A. Carestio (President and CEO) and John Adam Zangerle (Sr. VP, Gen Counsel, and Sec.) each sign 73.
Read moreShow less
Filings are published from February 18, 2016 to October 5, 2026. Annual volume peaks at 171 in 2019, after 103 in 2017, and stands at 28 in 2026. Over the last twelve months, 38 filings were published, of which 11 sales and no purchase.
